<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201508268650N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-04-01</date_registration>
      <primary_sponsor>Vice Chancellor for research of, Islamic Azad University branch of Medical Sciences Tehran</primary_sponsor>
      <public_title>Comparing the Open Endotracheal Suctioning and the Closed Endotracheal Suctioning Methods on the Level of Pain and Agitation of Patients under Mechanical Ventilation</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Open Endotracheal Suctioning and the Closed Endotracheal Suctioning Methods on the Level of Pain and Agitation of Patients under Mechanical Ventilation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2015-04-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/9140</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with impaired respiratory function in ICU.</hc_freetext>
      <i_freetext>Intervention 1: In the experimental group (open suction system) &#13;
In the beginning, The vital signs were recorded by the monitor. The patient was then hyper-oxygenized with 100% oxygen. Immediately after that, endotracheal suctioning (open) was conducted rotationally for 10 to 15 seconds with a maximum pressure of 120 mm Hg. Following that, the patient was again hyper-oxygenated with 100% oxygen, and hemodynamic variables were recorded at five temporal stages for both groups with the monitoring device. The pain and agitation of the two groups were measured using the Richmond Agitation Sedation Scale at five temporal stages (before, during, immediately, 5 minutes after the suctioning, and 15 minutes after the suctioning). Intervention 2: In the experimental group (close suction system) &#13;
In the beginning, The vital signs were recorded by the monitor. The patient was then hyper-oxygenized with 100% oxygen. Immediately after that, endotracheal suctioning(close) was conducted rotationally for 10 to 15 seconds with a maximum pressure of 120 mm Hg. Following that, the patient was again hyper-oxygenated with 100% oxygen, and hemodynamic variables were recorded at five temporal stages for both groups with the monitoring device. The pain and agitation of the two groups were measured using the Richmond Agitation Sedation Scale at five temporal stages (before, during, immediately, 5 minutes after the suctioning, and 15 minutes after the suctioning).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Raziyeh Dastdadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khaghani st, Shariati Ave, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>193951495</zip>
        <telephone>+98 21 2200 6660</telephone>
        <email>r.dastdadeh@gmail.com</email>
        <affiliation>School of Nursing and Midwifery, Islamic Azad University of Tehran</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Abbas Ebadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Molla sadra st,Tehran,Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>00</telephone>
        <email>ebadi1347@bmsu.ac.ir</email>
        <affiliation>Baqiyatallah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: The criteria for entering the study consisted of being 18 years of age or older, being an intubated (having a tube in the trachea) and mechanically ventilated patient, having a consciousness level with a Glasgow coma score of 7 or higher, having vital signs within normal limits, not having taken high-dose sedatives and tranquilizers (deep sedition) during the past six hours, having no severe facial trauma, taking dopamine, dobutamine and nitroglycerin according to the physician's orders (not taking them in unconventional doses), having a normal hearing and speaking ability and not being dependent on utilities such as hearing aids, not suffering from a neurological damage affecting breathing (such as quadriplegia), having no record of mental illness and severe neurological problems, and not being affected by neuromuscular diseases.&#13;
The exclusion criteria consisted of not receiving the patient’s companion’s consent, tracheal extubation, patient’s being in need of repeated suctioning or suctioning in intervals shorter than 20 minutes, having a reduced level of consciousness during suctioning, dysrhythmia, suffering from a reduced SPO2 level more than 10% during suctioning, and being in need of tranquilizers and painkillers more than the common treatment protocol.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>94 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J95 , J96 </hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other diseases of the respiratory system</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the experimental group (open suction system) &#13;
In the beginning, The vital signs were recorded by the monitor. The patient was then hyper-oxygenized with 100% oxygen. Immediately after that, endotracheal suctioning (open) was conducted rotationally for 10 to 15 seconds with a maximum pressure of 120 mm Hg. Following that, the patient was again hyper-oxygenated with 100% oxygen, and hemodynamic variables were recorded at five temporal stages for both groups with the monitoring device. The pain and agitation of the two groups were measured using the Richmond Agitation Sedation Scale at five temporal stages (before, during, immediately, 5 minutes after the suctioning, and 15 minutes after the suctioning).</i_keyword>
      <i_keyword>In the experimental group (close suction system) &#13;
In the beginning, The vital signs were recorded by the monitor. The patient was then hyper-oxygenized with 100% oxygen. Immediately after that, endotracheal suctioning(close) was conducted rotationally for 10 to 15 seconds with a maximum pressure of 120 mm Hg. Following that, the patient was again hyper-oxygenated with 100% oxygen, and hemodynamic variables were recorded at five temporal stages for both groups with the monitoring device. The pain and agitation of the two groups were measured using the Richmond Agitation Sedation Scale at five temporal stages (before, during, immediately, 5 minutes after the suctioning, and 15 minutes after the suctioning).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of Pain. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: BPS.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Agitation. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Richmond Agitation Sedation Scale.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Monitoring Device.</sec_outcome>
      <sec_outcome>SPO2. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Monitoring Device.</sec_outcome>
      <sec_outcome>Respiration rate. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Monitoring Device.</sec_outcome>
      <sec_outcome>Systolic Blood Pressure. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Monitoring Device.</sec_outcome>
      <sec_outcome>Mean Arterial Blood Pressure. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Monitoring Device.</sec_outcome>
      <sec_outcome>Diastolic Blood Pressure. Timepoint: Before, during, immediately after the intervention, 5 minutes and 15 minutes after intervention. Method of measurement: Monitoring Device.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellor for research of, Islamic Azad University branch of Medical Sciences Tehran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-02-24</approval_date>
        <contact_name>Islamic Azad University Ethics Committee Medical Branch of Tehran</contact_name>
        <contact_address>Khaghani st, Shariati Ave, Tehran, Iran Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
